{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:19:22Z","timestamp":1788977962775,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00726-015-1976-3","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T10:38:02Z","timestamp":1428575882000},"page":"1951-1959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Differential associations of circulating asymmetric dimethylarginine and cell adhesion molecules with metformin use in patients with type 2 diabetes mellitus and stable coronary artery disease"],"prefix":"10.1007","volume":"47","author":[{"given":"Olga","family":"Kruszelnicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadeta","family":"Chyrchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Golay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Surdacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,10]]},"reference":[{"key":"1976_CR1","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9149(01)02063-X","volume":"88","author":"F Abbasi","year":"2001","unstructured":"Abbasi F, Asagami T, Cooke JP, Lamendola C, McLaughlin T, Reaven GM, Stuehlinger M, Tsao PS (2001) Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol 88:1201\u20131203","journal-title":"Am J Cardiol"},{"key":"1976_CR2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.metabol.2003.07.020","volume":"53","author":"F Abbasi","year":"2004","unstructured":"Abbasi F, Chu JW, McLaughlin T, Lamendola C, Leary ET, Reaven GM (2004) Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus. Metabolism 53:159\u2013164","journal-title":"Metabolism"},{"key":"1976_CR3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1464-5491.2002.00663.x","volume":"19","author":"EJ Abbink","year":"2002","unstructured":"Abbink EJ, Pickkers P, Jansen van Rosendaal A, Lutterman JA, Tack CJ, Russel FG, Smits P (2002) Vascular effects of glibenclamide vs. glimepiride and metformin in type 2 diabetic patients. Diabet Med 19:136\u2013143","journal-title":"Diabet Med"},{"key":"1976_CR4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1479164110366053","volume":"7","author":"M Anderssohn","year":"2010","unstructured":"Anderssohn M, Schwedhelm E, L\u00fcneburg N, Vasan RS, B\u00f6ger RH (2010) Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus. Diab Vasc Dis Res 7:105\u2013118","journal-title":"Diab Vasc Dis Res"},{"key":"1976_CR5","doi-asserted-by":"crossref","first-page":"846","DOI":"10.2337\/dc13-0546","volume":"37","author":"M Anderssohn","year":"2014","unstructured":"Anderssohn M, McLachlan S, L\u00fcneburg N, Robertson C, Schwedhelm E, Williamson RM, Strachan MW, Ajjan R, Grant PJ, B\u00f6ger RH, Price JF (2014) Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetes. Diabetes Care 37:846\u2013854","journal-title":"Diabetes Care"},{"key":"1976_CR6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1053\/meta.2002.33349","volume":"51","author":"T Asagami","year":"2002","unstructured":"Asagami T, Abbasi F, Stuelinger M, Lamendola C, McLaughlin T, Cooke JP, Reaven GM, Tsao PS (2002) Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes. Metabolism 51:843\u2013846","journal-title":"Metabolism"},{"key":"1976_CR7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.diabres.2014.08.028","volume":"106","author":"F Bal","year":"2014","unstructured":"Bal F, Bekpinar S, Unlucerci Y, Kusku-Kiraz Z, Onder S, Uysal M, Gurdol F (2014) Antidiabetic drug metformin is effective on the metabolism of asymmetric dimethylarginine in experimental liver injury. Diabetes Res Clin Pract 106:295\u2013302","journal-title":"Diabetes Res Clin Pract"},{"key":"1976_CR8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000332382","volume":"1","author":"WH Bestermann Jr","year":"2011","unstructured":"Bestermann WH Jr (2011) The ADMA-metformin hypothesis: linking the cardiovascular consequences of the metabolic syndrome and type 2 diabetes. Cardiorenal Med 1:211\u2013219","journal-title":"Cardiorenal Med"},{"key":"1976_CR9","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1161\/hc3701.095949","volume":"104","author":"S Blankenberg","year":"2001","unstructured":"Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, Tiret L, Meyer J (2001) Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 104:1336\u20131342","journal-title":"Circulation"},{"key":"1976_CR10","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/CIRCULATIONAHA.108.838268","volume":"119","author":"RH B\u00f6ger","year":"2009","unstructured":"B\u00f6ger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, Benjamin EJ, Schulze F, Xanthakis V, Benndorf RA, Vasan RS (2009) Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation 119:1592\u20131600","journal-title":"Circulation"},{"key":"1976_CR11","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1210\/jc.2004-0019","volume":"89","author":"AE Caballero","year":"2004","unstructured":"Caballero AE, Delgado A, Aguilar-Salinas CA, Herrera AN, Castillo JL, Cabrera T, Gomez-Perez FJ, Rull JA (2004) The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial. J Clin Endocrinol Metab 89:3943\u20133948","journal-title":"J Clin Endocrinol Metab"},{"key":"1976_CR12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2009.10.034","volume":"210","author":"E Cavusoglu","year":"2010","unstructured":"Cavusoglu E, Ruwende C, Chopra V, Poludasu S, Yanamadala S, Frishman WH, Eng C, Pinsky DJ, Marmur JD (2010) Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at 2\u00a0years in men with diabetes mellitus referred for coronary angiography. Atherosclerosis 210:226\u2013231","journal-title":"Atherosclerosis"},{"key":"1976_CR13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.niox.2011.08.003","volume":"25","author":"K Chobanyan-J\u00fcrgens","year":"2011","unstructured":"Chobanyan-J\u00fcrgens K, Pham VV, Stichtenoth DO, Tsikas D (2011) Elevated dimethylarginine dimethylaminohydrolase (DDAH) activity in rheumatoid arthritis and spondyloarthritis. Nitric Oxide 25:436\u2013438","journal-title":"Nitric Oxide"},{"key":"1976_CR14","doi-asserted-by":"crossref","first-page":"H1530","DOI":"10.1152\/ajpheart.00823.2007","volume":"294","author":"MJ Crabtree","year":"2008","unstructured":"Crabtree MJ, Smith CL, Lam G, Goligorsky MS, Gross SS (2008) Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS. Am J Physiol Heart Circ Physiol 294:H1530\u2013H1540","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1976_CR15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2796.2004.01420.x","volume":"257","author":"J Jager de","year":"2005","unstructured":"de Jager J, Kooy A, Lehert P, Bets D, Wulffel\u00e9 MG, Teerlink T, Scheffer PG, Schalkwijk CG, Donker AJ, Stehouwer CD (2005) Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med 257:100\u2013109","journal-title":"J Intern Med"},{"key":"1976_CR16","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/01.ATV.0000215951.36219.a4","volume":"26","author":"J Jager de","year":"2006","unstructured":"de Jager J, Dekker JM, Kooy A, Kostense PJ, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD (2006) Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn Study. Arterioscler Thromb Vasc Biol 26:1086\u20131093","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1976_CR17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/joim.12128","volume":"275","author":"J Jager de","year":"2014","unstructured":"de Jager J, Kooy A, Schalkwijk C, van der Kolk J, Lehert P, Bets D, Wulffel\u00e9 MG, Donker AJ, Stehouwer CD (2014) Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial. J Intern Med 275:59\u201370","journal-title":"J Intern Med"},{"key":"1976_CR18","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0006-2952(02)00858-4","volume":"63","author":"D Detaille","year":"2002","unstructured":"Detaille D, Guigas B, Leverve X, Wiernsperger N, Devos P (2002) Obligatory role of membrane events in the regulatory effect of metformin on the respiratory chain function. Biochem Pharmacol 63:1259\u20131272","journal-title":"Biochem Pharmacol"},{"key":"1976_CR19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.amjhyper.2005.01.004","volume":"18","author":"LJ Dixon","year":"2005","unstructured":"Dixon LJ, Hughes SM, Rooney K, Madden A, Devine A, Leahey W, Henry W, Johnston GD, McVeigh GE (2005) Increased superoxide production in hypertensive patients with diabetes mellitus: role of nitric oxide synthase. Am J Hypertens 18:839\u2013843","journal-title":"Am J Hypertens"},{"key":"1976_CR20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.metabol.2006.11.003","volume":"56","author":"HM Eid","year":"2007","unstructured":"Eid HM, Reims H, Arnesen H, Kjeldsen SE, Lyberg T, Seljeflot I (2007) Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia. Metabolism 56:464\u2013469","journal-title":"Metabolism"},{"key":"1976_CR21","doi-asserted-by":"crossref","first-page":"e96062","DOI":"10.1371\/journal.pone.0096062","volume":"9","author":"S Messaoudi El","year":"2014","unstructured":"El Messaoudi S, Schreuder TH, Kengen RD, Rongen GA, van den Broek PH, Thijssen DH, Riksen NP (2014) Impact of metformin on endothelial ischemia-reperfusion injury in humans in vivo: a prospective randomized open, blinded-endpoint study. PLoS One 9:e96062","journal-title":"PLoS One"},{"key":"1976_CR22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00592-011-0276-y","volume":"48","author":"E Fidan","year":"2011","unstructured":"Fidan E, Onder Ersoz H, Yilmaz M, Yilmaz H, Kocak M, Karahan C, Eren C (2011) The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus. Acta Diabetol 48:297\u2013302","journal-title":"Acta Diabetol"},{"key":"1976_CR23","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1161\/01.CIR.0000012748.58444.08","volume":"105","author":"TJ Guzik","year":"2002","unstructured":"Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM (2002) Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105:1656\u20131662","journal-title":"Circulation"},{"key":"1976_CR24","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1161\/01.RES.88.2.e14","volume":"88","author":"U Hink","year":"2001","unstructured":"Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, M\u00fcnzel T (2001) Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88:E14\u2013E22","journal-title":"Circ Res"},{"key":"1976_CR25","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577\u20131589","journal-title":"N Engl J Med"},{"key":"1976_CR26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12933-014-0156-1","volume":"13","author":"CP Hsu","year":"2014","unstructured":"Hsu CP, Hsu PF, Chung MY, Lin SJ, Lu TM (2014) Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control. Cardiovasc Diabetol 13:156","journal-title":"Cardiovasc Diabetol"},{"key":"1976_CR27","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-012-2534-0","volume":"55","author":"SE Inzucchi","year":"2012","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR (2012) Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 55:1577\u20131596","journal-title":"Diabetologia"},{"key":"1976_CR28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2337\/diabetes.49.3.485","volume":"49","author":"A Jager","year":"2000","unstructured":"Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, ter Wee PM, van Guldener C (2000) Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes 49:485\u2013491","journal-title":"Diabetes"},{"key":"1976_CR29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1463-1326.2005.00568.x","volume":"8","author":"A Kautzky-Willer","year":"2006","unstructured":"Kautzky-Willer A, Tura A, Winzer C, Wagner OF, Ludvik B, Hanusch-Enserer U, Prager R, Pacini G (2006) Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione. Diabetes Obes Metab 8:561\u2013567","journal-title":"Diabetes Obes Metab"},{"key":"1976_CR30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.atherosclerosis.2008.10.040","volume":"205","author":"S Kiechl","year":"2009","unstructured":"Kiechl S, Lee T, Santer P, Thompson G, Tsimikas S, Egger G, Holt DW, Willeit J, Xu Q, Mayr M (2009) Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population. Atherosclerosis 205:261\u2013265","journal-title":"Atherosclerosis"},{"key":"1976_CR31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.metabol.2007.08.013","volume":"57","author":"D Konukoglu","year":"2008","unstructured":"Konukoglu D, Firtina S, Serin O (2008) The relationship between plasma asymmetrical dimethyl-l-arginine and inflammation and adhesion molecule levels in subjects with normal, impaired, and diabetic glucose tolerance. Metabolism 57:110\u2013115","journal-title":"Metabolism"},{"key":"1976_CR32","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1253\/circj.CJ-12-0428","volume":"76","author":"M Koshizaka","year":"2012","unstructured":"Koshizaka M, Green JB, Alexander JH (2012) Glycemic management in diabetes and the associated cardiovascular risk\u2014are we helping or hurting our patients? Circ J 76:1572\u20131580","journal-title":"Circ J"},{"key":"1976_CR33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00125-013-3082-y","volume":"57","author":"O Kruszelnicka","year":"2014","unstructured":"Kruszelnicka O (2014) Nitric oxide vs insulin secretion, action and clearance. Diabetologia 57:257\u2013258","journal-title":"Diabetologia"},{"key":"1976_CR34","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2337\/dc07-0019","volume":"30","author":"K Krzyzanowska","year":"2007","unstructured":"Krzyzanowska K, Mittermayer F, Wolzt M, Schernthaner G (2007) Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes. Diabetes Care 30:1834\u20131839","journal-title":"Diabetes Care"},{"key":"1976_CR35","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/ATVBAHA.107.156596","volume":"28","author":"T Leong","year":"2008","unstructured":"Leong T, Zylberstein D, Graham I, Lissner L, Ward D, Fogarty J, Bengtsson C, Bj\u00f6rkelund C, Thelle D, Collaboration Swedish-Irish-Norwegian (2008) Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg. Arterioscler Thromb Vasc Biol 28:961\u2013967","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1976_CR36","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.CIR.0000027109.14149.67","volume":"106","author":"KY Lin","year":"2002","unstructured":"Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JP (2002) Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 106:987\u2013992","journal-title":"Circulation"},{"key":"1976_CR37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2011.06.120","volume":"153","author":"TM Lu","year":"2011","unstructured":"Lu TM, Chung MY, Lin MW, Hsu CP, Lin SJ (2011) Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography. Int J Cardiol 153:135\u2013140","journal-title":"Int J Cardiol"},{"key":"1976_CR38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1530\/EJE-07-0815","volume":"158","author":"SS Lund","year":"2008","unstructured":"Lund SS, Tarnow L, Stehouwer CD, Schalkwijk CG, Teerlink T, Gram J, Winther K, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA (2008) Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes. Eur J Endocrinol 158:631\u2013641","journal-title":"Eur J Endocrinol"},{"key":"1976_CR39","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2337\/diacare.19.9.934","volume":"19","author":"R Marfella","year":"1996","unstructured":"Marfella R, Acampora R, Verrazzo G, Ziccardi P, De Rosa N, Giunta R, Giuliano D (1996) Metformin improves hemodynamic and rheological responses to l-arginine in NIDDM patients. Diabetes Care 19:934\u2013939","journal-title":"Diabetes Care"},{"key":"1976_CR40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00125-005-0066-6","volume":"49","author":"EB Marliss","year":"2006","unstructured":"Marliss EB, Chevalier S, Gougeon R, Morais JA, Lamarche M, Adegoke OA, Wu G (2006) Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover. Diabetologia 49:351\u2013359","journal-title":"Diabetologia"},{"key":"1976_CR41","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1016\/j.jchromb.2009.07.003","volume":"877","author":"J Martens-Lobenhoffer","year":"2009","unstructured":"Martens-Lobenhoffer J, Schwedhelm E, Tsikas D (2009) Quantification of arginine and its mono- and dimethylated analogs NMMA, ADMA and SDMA in biological fluids by LC-MS\/MS: is LC superfluous? J Chromatogr B Analyt Technol Biomed Life Sci 877:3261\u20133266","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1976_CR42","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0735-1097(01)01129-9","volume":"37","author":"KJ Mather","year":"2001","unstructured":"Mather KJ, Verma S, Anderson TJ (2001) Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol 37:1344\u20131350","journal-title":"J Am Coll Cardiol"},{"key":"1976_CR43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1373\/clinchem.2006.076711","volume":"53","author":"A Meinitzer","year":"2007","unstructured":"Meinitzer A, Seelhorst U, Wellnitz B, Halwachs-Baumann G, Boehm BO, Winkelmann BR, M\u00e4rz W (2007) Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study). Clin Chem 53:273\u2013283","journal-title":"Clin Chem"},{"key":"1976_CR44","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2010.150854","volume":"57","author":"A Meinitzer","year":"2011","unstructured":"Meinitzer A, Kielstein JT, Pilz S, Drechsler C, Ritz E, Boehm BO, Winkelmann BR, M\u00e4rz W (2011) Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem 57:112\u2013121","journal-title":"Clin Chem"},{"key":"1976_CR45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/1479164111424515","volume":"9","author":"KK Naka","year":"2012","unstructured":"Naka KK, Papathanassiou K, Bechlioulis A, Pappas K, Kazakos N, Kanioglou C, Kostoula A, Vezyraki P, Makriyiannis D, Tsatsoulis A, Michalis LK (2012) Effects of pioglitazone and metformin on vascular endothelial function in patients with type 2 diabetes treated with sulfonylureas. Diab Vasc Dis Res 9:52\u201358","journal-title":"Diab Vasc Dis Res"},{"key":"1976_CR46","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2337\/diacare.27.6.1349","volume":"27","author":"A Natali","year":"2004","unstructured":"Natali A, Baldeweg S, Toschi E, Capaldo B, Barbaro D, Gastaldelli A, Yudkin JS, Ferrannini E (2004) Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes. Diabetes Care 27:1349\u20131357","journal-title":"Diabetes Care"},{"key":"1976_CR47","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/meta.2003.50048","volume":"52","author":"H P\u00e4iv\u00e4","year":"2003","unstructured":"P\u00e4iv\u00e4 H, Lehtim\u00e4ki T, Laakso J, Ruokonen I, Rantalaiho V, Wirta O, Pasternack A, Laaksonen R (2003) Plasma concentrations of asymmetric-dimethyl-l-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy. Metabolism 52:303\u2013307","journal-title":"Metabolism"},{"key":"1976_CR48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/dom.12041","volume":"15","author":"D Pitocco","year":"2013","unstructured":"Pitocco D, Zaccardi F, Tarzia P, Milo M, Scavone G, Rizzo P, Pagliaccia F, Nerla R, Di Franco A, Manto A, Rocca B, Lanza GA, Crea F, Ghirlanda G (2013) Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study. Diabetes Obes Metab 15:427\u2013431","journal-title":"Diabetes Obes Metab"},{"key":"1976_CR49","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-157-9-201211060-00003","volume":"157","author":"CL Roumie","year":"2012","unstructured":"Roumie CL, Hung AM, Greevy RA, Grijalva CG, Liu X, Murff HJ, Elasy TA, Griffin MR (2012) Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study. Ann Intern Med 157:601\u2013610","journal-title":"Ann Intern Med"},{"key":"1976_CR50","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/archinternmed.2010.409","volume":"170","author":"R Roussel","year":"2010","unstructured":"Roussel R, Travert F, Pasquet B, Wilson PW, Smith SC, Goto S, Ravaud P, Marre M, Porath A, Bhatt DL, Steg PG, Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators (2010) Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med 170:1892\u20131899","journal-title":"Arch Intern Med"},{"key":"1976_CR51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.diabet.2013.02.006","volume":"39","author":"AJ Scheen","year":"2013","unstructured":"Scheen AJ, Paquot N (2013) Metformin revisited: a critical review of the benefit-risk balance in at-risk patients with type 2 diabetes. Diabetes Metab 39:179\u2013190","journal-title":"Diabetes Metab"},{"key":"1976_CR52","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/01.RES.0000181286.44222.61","volume":"97","author":"R Schnabel","year":"2005","unstructured":"Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-Klein C, Jachmann N, Post F, Peetz D, Bickel C, Cambien F, Tiret L, M\u00fcnzel T (2005) Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res 97:e53\u2013e59","journal-title":"Circ Res"},{"key":"1976_CR53","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.CCM.0000155784.59297.50","volume":"33","author":"MP Siroen","year":"2005","unstructured":"Siroen MP, van Leeuwen PA, Nijveldt RJ, Teerlink T, Wouters PJ, Van den Berghe G (2005) Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Crit Care Med 33:504\u2013510","journal-title":"Crit Care Med"},{"key":"1976_CR54","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00228-007-0378-1","volume":"63","author":"J Skrha","year":"2007","unstructured":"Skrha J, Pr\u00e1zn\u00fd M, Hilgertov\u00e1 J, Kvasnicka J, Kalousov\u00e1 M, Zima T (2007) Oxidative stress and endothelium influenced by metformin in type 2 diabetes mellitus. Eur J Clin Pharmacol 63:1107\u20131114","journal-title":"Eur J Clin Pharmacol"},{"key":"1976_CR55","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.yjmcc.2012.06.002","volume":"53","author":"J Strobel","year":"2012","unstructured":"Strobel J, Mieth M, Endress B, Auge D, K\u00f6nig J, Fromm MF, Maas R (2012) Interaction of the cardiovascular risk marker asymmetric dimethylarginine (ADMA) with the human cationic amino acid transporter 1 (CAT1). J Mol Cell Cardiol 53:392\u2013400","journal-title":"J Mol Cell Cardiol"},{"key":"1976_CR56","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00726-013-1556-3","volume":"45","author":"J Strobel","year":"2013","unstructured":"Strobel J, M\u00fcller F, Zolk O, Endre\u00df B, K\u00f6nig J, Fromm MF, Maas R (2013) Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1). Amino Acids 45:989\u20131002","journal-title":"Amino Acids"},{"key":"1976_CR57","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.287.11.1420","volume":"287","author":"MC St\u00fchlinger","year":"2002","unstructured":"St\u00fchlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, Reaven GM, Tsao PS (2002) Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 287:1420\u20131426","journal-title":"JAMA"},{"key":"1976_CR58","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/ndt\/gfp439","volume":"25","author":"A Surdacki","year":"2010","unstructured":"Surdacki A, Marewicz E, Wieczorek-Surdacka E, Rakowski T, Szastak G, Pryjma J, Dudek D, Dubiel JS (2010) Synergistic effects of asymmetrical dimethyl-l-arginine accumulation and endothelial progenitor cell deficiency on renal function decline during a 2-year follow-up in stable angina. Nephrol Dial Transplant 25:2576\u20132583","journal-title":"Nephrol Dial Transplant"},{"key":"1976_CR59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1567-5688(06)80065-6","volume":"7","author":"T Teerlink","year":"2006","unstructured":"Teerlink T, Heine RJ, Nijpels G, Bouter LM, Stehouwer CDA, Dekker JM (2006) Asymmetric dimethylarginine (ADMA) is associated with incident cardiovascular disease in the general population. The Hoorn study. Atheroscler Suppl 7:23 Abstract","journal-title":"The Hoorn study. Atheroscler Suppl"},{"key":"1976_CR60","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.phrs.2009.08.002","volume":"60","author":"T Teerlink","year":"2009","unstructured":"Teerlink T, Luo Z, Palm F, Wilcox CS (2009) Cellular ADMA: regulation and action. Pharmacol Res 60:448\u2013460","journal-title":"Pharmacol Res"},{"key":"1976_CR61","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.trsl.2014.07.005","volume":"164","author":"CM Tsai","year":"2014","unstructured":"Tsai CM, Kuo HC, Hsu CN, Huang LT, Tain YL (2014) Metformin reduces asymmetric dimethylarginine and prevents hypertension in spontaneously hypertensive rats. Transl Res 164:452\u2013459","journal-title":"Transl Res"},{"key":"1976_CR62","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications on overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854\u2013865","journal-title":"Lancet"},{"key":"1976_CR63","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/ATVBAHA.109.185645","volume":"29","author":"Z Wang","year":"2009","unstructured":"Wang Z, Tang WH, Cho L, Brennan DM, Hazen SL (2009) Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition. Arterioscler Thromb Vasc Biol 29:1383\u20131391","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1976_CR64","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3892\/etm.2014.1582","volume":"7","author":"S Wu","year":"2014","unstructured":"Wu S, Li X, Zhang H (2014) Effects of metformin on endothelial function in type 2 diabetes. Exp Ther Med 7:1349\u20131353","journal-title":"Exp Ther Med"},{"key":"1976_CR65","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","volume":"358","author":"C Zoccali","year":"2001","unstructured":"Zoccali C, Bode-B\u00f6ger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Fr\u00f6lich J, B\u00f6ger R (2001) Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358:2113\u20132117","journal-title":"Lancet"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-015-1976-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-015-1976-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-015-1976-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T01:39:40Z","timestamp":1566524380000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-015-1976-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,10]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["1976"],"URL":"https:\/\/doi.org\/10.1007\/s00726-015-1976-3","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,10]]}}}